Cargando…
Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models
An efficacious HIV vaccine is urgently needed to curb the AIDS pandemic. The modest protection elicited in the phase III clinical vaccine trial in Thailand provided hope that this goal might be achieved. However, new approaches are necessary for further advances. As HIV is transmitted primarily acro...
Autores principales: | Tuero, Iskra, Robert-Guroff, Marjorie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147690/ https://www.ncbi.nlm.nih.gov/pubmed/25196380 http://dx.doi.org/10.3390/v6083129 |
Ejemplares similares
-
Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector
por: Thomas, Michael A., et al.
Publicado: (2016) -
The Immunological Impact of Adenovirus Early Genes on Vaccine-Induced Responses in Mice and Nonhuman Primates
por: Sangare, Kotou, et al.
Publicado: (2021) -
The Use of Nonhuman Primate Models in HIV Vaccine Development
por: Morgan, Cecilia, et al.
Publicado: (2008) -
Replicating and non-replicating viral vectors for vaccine development
por: Robert-Guroff, Marjorie
Publicado: (2007) -
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
por: Tuero, Iskra, et al.
Publicado: (2015)